Jun-29-22 05:00PM | |
Jun-28-22 05:50PM | |
Jun-24-22 05:30AM | |
Jun-23-22 11:47AM | |
08:59AM | |
Jun-22-22 05:50PM | |
Jun-21-22 04:30PM | |
Jun-16-22 05:45PM | |
Jun-15-22 11:40AM | |
Jun-08-22 07:30AM | |
Jun-06-22 05:50PM | |
12:00PM | |
12:00PM | |
Jun-02-22 02:41PM | |
11:31AM | |
07:14AM | |
May-30-22 11:40AM | |
May-17-22 03:37PM | |
May-13-22 09:02AM | |
May-12-22 04:30PM | |
May-10-22 04:15PM | |
07:43AM | |
May-09-22 03:01PM | |
11:00AM | |
May-08-22 09:17AM | |
May-04-22 04:30PM | |
May-02-22 03:25PM | |
Apr-25-22 02:15PM | |
Apr-21-22 12:00PM | |
10:04AM | |
07:24AM | |
07:15AM | |
06:00AM | |
Apr-20-22 06:55AM | |
Apr-19-22 11:52AM | |
10:51AM | |
10:49AM | |
Apr-18-22 03:54PM | |
Apr-12-22 04:30PM | |
Apr-08-22 11:40AM | |
Apr-07-22 08:56AM | |
Apr-06-22 05:42PM | Investor's Business Daily |
Apr-04-22 03:19AM | |
Mar-31-22 06:15PM | |
Mar-28-22 09:00AM | |
Mar-25-22 06:00PM | |
01:15PM | |
06:45AM | |
Mar-24-22 06:15PM | |
03:20PM | |
12:30PM | |
06:09AM | |
Mar-23-22 05:20PM | |
Mar-21-22 04:30PM | |
08:55AM | |
Mar-17-22 06:15PM | |
02:03PM | |
Mar-11-22 06:00PM | |
Mar-10-22 06:15PM | |
12:48PM | |
12:17PM | |
Mar-07-22 12:07PM | |
Mar-04-22 06:00PM | |
08:35AM | |
Mar-03-22 11:40AM | |
Mar-01-22 04:30PM | |
Feb-23-22 04:15PM | |
Feb-14-22 10:52AM | |
Feb-10-22 04:44PM | |
Feb-08-22 10:38AM | |
Feb-07-22 05:38PM | |
01:38PM | |
09:38AM | |
Feb-04-22 02:38PM | |
Feb-03-22 01:38PM | |
01:38PM | |
08:15AM | |
Feb-02-22 05:38PM | |
03:06PM | |
09:38AM | |
09:38AM | |
Feb-01-22 01:38PM | |
09:38AM | |
Jan-31-22 05:38PM | |
01:38PM | |
07:13AM | |
Jan-28-22 08:42PM | |
05:38PM | |
Jan-27-22 01:38PM | |
11:12AM | |
07:15AM | |
06:00AM | |
Jan-26-22 10:52AM | |
10:30AM | |
Jan-25-22 01:38PM | |
12:09PM | |
11:54AM | |
11:10AM | |
10:29AM | |
09:38AM | |
|
|
|
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RALES MITCHELL P | Chairman of Exec. Committee | May 16 | Buy | 247.89 | 200 | 49,578 | 3,256 | May 17 04:20 PM | Weidemanis Joakim | Executive Vice President | Apr 25 | Sale | 255.74 | 6,500 | 1,662,278 | 86,398 | Apr 27 05:05 PM | Ellis Brian W | Senior Vice President - GC | Feb 02 | Sale | 293.99 | 5,365 | 1,577,248 | 12,374 | Feb 03 05:06 PM | Weidemanis Joakim | Executive Vice President | Jan 31 | Option Exercise | 46.13 | 20,508 | 946,034 | 84,351 | Feb 02 05:04 PM | Weidemanis Joakim | Executive Vice President | Jan 31 | Sale | 285.24 | 20,508 | 5,849,753 | 63,843 | Feb 02 05:04 PM | Raskas Daniel | SVP - Corporate Development | Nov 30 | Option Exercise | 46.13 | 12,294 | 567,122 | 34,538 | Dec 01 05:02 PM | Raskas Daniel | SVP - Corporate Development | Nov 30 | Sale | 326.00 | 12,294 | 4,007,844 | 22,244 | Dec 01 05:02 PM | Lalor Angela S | SVP, Human Resources | Nov 29 | Option Exercise | 65.83 | 37,513 | 2,469,481 | 68,450 | Nov 30 05:10 PM | Zerhouni Elias A. | Director | Nov 29 | Sale | 328.42 | 3,409 | 1,119,594 | 25,139 | Nov 30 05:13 PM | Lalor Angela S | SVP, Human Resources | Nov 29 | Sale | 327.00 | 37,513 | 12,266,751 | 30,937 | Nov 30 05:10 PM | Raskas Daniel | SVP - Corporate Development | Nov 26 | Option Exercise | 46.13 | 12,300 | 567,399 | 34,850 | Nov 30 05:01 PM | McGrew Matthew | EVP & Chief Financial Officer | Nov 26 | Sale | 325.50 | 2,589 | 842,720 | 6,811 | Nov 30 05:06 PM | Raskas Daniel | SVP - Corporate Development | Nov 26 | Sale | 325.33 | 12,300 | 4,001,522 | 22,550 | Nov 30 05:01 PM | HEFNER LINDA P | Director | Nov 18 | Option Exercise | 43.92 | 8,038 | 353,027 | 52,024 | Nov 19 05:01 PM | HEFNER LINDA P | Director | Nov 18 | Sale | 308.85 | 4,548 | 1,404,627 | 47,476 | Nov 19 05:01 PM | HEFNER LINDA P | Director | Nov 11 | Sale | 303.72 | 2,185 | 663,628 | 43,986 | Nov 12 07:43 AM | Weidemanis Joakim | Executive Vice President | Nov 10 | Sale | 297.55 | 5,000 | 1,487,750 | 65,720 | Nov 12 07:40 AM | RALES MITCHELL P | Chairman of Exec. Committee | Nov 04 | Sale | 305.99 | 194,257 | 59,440,699 | 0 | Nov 04 06:42 PM | RALES MITCHELL P | Chairman of Exec. Committee | Nov 04 | Sale | 305.85 | 343,862 | 105,169,373 | 1,181,366 | Nov 04 06:42 PM | RALES MITCHELL P | Chairman of Exec. Committee | Nov 03 | Sale | 307.35 | 343,861 | 105,686,760 | 1,525,228 | Nov 04 06:42 PM | RALES MITCHELL P | Chairman of Exec. Committee | Nov 02 | Sale | 312.94 | 343,861 | 107,609,073 | 1,869,089 | Nov 04 06:42 PM | LUTZ ROBERT S | SVP-Chief Accounting Officer | Aug 13 | Option Exercise | 57.90 | 5,000 | 289,500 | 21,155 | Aug 17 05:22 PM | LUTZ ROBERT S | SVP-Chief Accounting Officer | Aug 13 | Sale | 313.40 | 5,000 | 1,567,001 | 16,155 | Aug 17 05:22 PM | Weidemanis Joakim | Executive Vice President | Jul 30 | Sale | 298.93 | 6,700 | 2,002,818 | 70,720 | Aug 02 05:03 PM | McGrew Matthew | EVP & Chief Financial Officer | Jul 28 | Option Exercise | 46.13 | 12,310 | 567,860 | 16,236 | Jul 29 05:02 PM | Ellis Brian W | SVP and General Counsel | Jul 28 | Option Exercise | 65.95 | 12,000 | 791,400 | 33,334 | Jul 29 05:07 PM | Ellis Brian W | SVP and General Counsel | Jul 28 | Sale | 291.00 | 12,000 | 3,492,000 | 21,334 | Jul 29 05:07 PM | McGrew Matthew | EVP & Chief Financial Officer | Jul 28 | Sale | 293.40 | 12,310 | 3,611,782 | 9,400 | Jul 29 05:02 PM | Weidemanis Joakim | Executive Vice President | Jul 27 | Option Exercise | 40.45 | 9,467 | 382,940 | 86,887 | Jul 28 05:04 PM | Weidemanis Joakim | Executive Vice President | Jul 27 | Sale | 289.45 | 16,467 | 4,766,435 | 77,420 | Jul 28 05:04 PM | HEFNER LINDA P | Director | Jul 26 | Option Exercise | 38.12 | 4,350 | 165,822 | 46,430 | Jul 28 05:03 PM |
|